ACLA

Jun 16, 2022

VALID Act Passes Out of Senate HELP Committee, But Potential Cracks in Support Appear
Premium

May 17, 2022

Senate Releases Updated Version of VALID Act Attached to MDUFA Legislative Package

May 5, 2022

Post-EUA Regulatory Landscape for COVID-19 Tests Coming Into View, But Details Remain Fuzzy
Premium

May 3, 2022

Labs Worry End of HRSA Funding Could Impact Access to COVID-19 Testing for Uninsured
Premium

Mar 16, 2022

FDA Control of LDTs Looms as Momentum Builds for VALID Act
Premium

Dec 23, 2021

Amidst Backdrop of COVID-19 Pandemic, Labs Make Strong Showing in 2021
Premium

Dec 21, 2021

Lab Industry Hoping for Permanent Fix to PAMA in 2022
Premium

Dec 17, 2021

Despite PAMA Delays, Lab Industry Stakeholders Fear Impact of Future Reimbursement Cuts
Premium

Nov 15, 2021

FDA, HHS Update COVID-19 Test Emergency Use Authorization Policies

Sep 10, 2021

Biden Administration Details Expanded Testing as Part of Broader COVID-19 Action Plan

Aug 19, 2021

Recent Prosecutions Give Labs Insight Into DOJ's Use of Opioid Bill's Anti-Kickback Statute
Premium

Jun 24, 2021

US House and Senate Reintroduce Bill That Would Give FDA Authority to Regulate LDTs

Jun 1, 2021

ACLA Files Notice of Appeal in PAMA Lawsuit

Mar 24, 2021

Labs Left Outside Value-Based Care Arrangements by Stark, Anti-Kickback Reforms
Premium

Mar 12, 2021

COVID-19 Pandemic Changing Digital Innovations, Care Models for Lab Industry, Panelists Say at ACLA
Premium

Jan 21, 2021

President Biden Announces Plan to Expand SARS-CoV-2 Testing, Increase Capacity

Jan 21, 2021

Lab Stakeholders Welcome Biden Moves on COVID-19 Testing, Suggest Additional Steps
Premium

Jan 15, 2021

Biden Unveils Economic Plan to Provide $50B for COVID-19 Testing Expansion

Dec 3, 2020

Will US Ever Get to Mass Testing for COVID-19?

Nov 17, 2020

HHS Instructs FDA to Resume Review of EUA Submissions for SARS-CoV-2 LDTs